A Multi-centre Randomized Controlled Trial to Assess Feasibility and Safety of Adjunctive Treatment With the HemoSystem REBOOT in Critically Ill patientS wiTh Sepsis-induced Immunosuppression
The aim of this randomized controlled trial is to restore immune function by selectively removing three mediators largely contributing to sepsis-induced immunosuppression from extracorporeal circulation.
100 项与 hemotune AG 相关的临床结果
0 项与 hemotune AG 相关的专利(医药)
100 项与 hemotune AG 相关的药物交易
100 项与 hemotune AG 相关的转化医学